/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Angelica Ferrando‐Díez

Badalona Serveis Assistencials(ES)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

18

Papers

85

Citations

5

h-index

2

i10-index

Angelica Ferrando‐Díez is an academic researcher from Badalona Serveis Assistencials. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies. The author has an h-index of 5, co-authored 16 publications.

ORCID: 0000-0003-0206-7498

Research Topics

Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research Breast Cancer Treatment Studies Monoclonal and Polyclonal Antibodies Research Cervical Cancer and HPV Research

Papers by this author

works

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data

2022 · The Breast · 11 citations

https://doi.org/10.1016/j.breast.2022.01.007

Adrià Bernat‐Peguera Macedonia Trigueros Angelica Ferrando‐Díez Cristina Ibáñez

Abstract PS4-02-23: Biomarkers of response and resistance to Sacituzumab Govitecan in HR+/HER2− advanced breast cancer: interim results from the phase II SOLTI ACROSS-TROP2 Trial

2026 · Clinical Cancer Research · 0 citations

https://doi.org/10.1158/1557-3265.sabcs25-ps4-02-23

E. Ciruelos T. Pascual B. Adamo M. Alva Bianchi

Research topics

topics

Advanced Breast Cancer Therapies

HER2/EGFR in Cancer Research

Breast Cancer Treatment Studies

Monoclonal and Polyclonal Antibodies Research

Cervical Cancer and HPV Research

Chat about Author

Papers

Chat

Click to start Chat